Combined CDKN1A/TP53 Mutation in Bladder Cancer Is a Therapeutic Target

Title
Combined CDKN1A/TP53 Mutation in Bladder Cancer Is a Therapeutic Target
Authors
Keywords
-
Journal
MOLECULAR CANCER THERAPEUTICS
Volume 14, Issue 1, Pages 174-182
Publisher
American Association for Cancer Research (AACR)
Online
2014-10-28
DOI
10.1158/1535-7163.mct-14-0622-t

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now